advertisement
Advertisement (image not found)

Patent News

Page
12345»

Myriad Breast Cancer Patent Very Broad, Study Finds

Myriad Genetics' disputed patent on the BRCA1 breast cancer gene is "surprisingly...

Wednesday, March 17, 2010 Source: Reuters

Epeius Biotechnologies Receives Notice Of Patent Allowance For Tumor-Targeted Cancer Vaccines

Epeius Biotechnologies Corporation, an emerging leader in the field of targeted...

Tuesday, March 16, 2010 Source: Epeius Biotechnologies

AlloSource Granted Patent For Proprietary Tissue Cleaning And Disinfecting Process

AlloSource, one of the nation's largest non-profit providers of skin, bone and...

Monday, March 15, 2010 Source: AlloSource

Roche Diagnostics Purchases Microarray Instrument And Accessory Assets From BioMicro Systems

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that the U.S. Patent and...

Friday, March 12, 2010 Source: Seattle Genetics, Inc.

Bone Biologics Announces A Major US Patent Issuance For Its Recombinant Protein Process For The Formation Of Cartilage

Bone Biologics, Inc. announced today that it has received a US Patent Office...

Thursday, March 11, 2010 Source: Bone Biologics, Inc.

Bone Biologics Announces Another Major US Patent Issuance For Recombinant Protein Process

Bone Biologics, Inc. announced today that it has received a US Patent Office...

Thursday, March 11, 2010 Source: Bone Biologics, Inc.

Smith & Nephew Announces Next Steps In Patent Infringement Litigation

The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc...

Wednesday, March 10, 2010 Source: Smith & Nephew Inc.

VIVUS Announces The Issuances Of Three Additional Qnexa® Patents

VIVUS, Inc. today announced the issuance of three additional patents by the U.S...

Monday, March 08, 2010 Source: VIVUS, Inc.

Sandata Technologies And Infocrossing Settle Patent Infringement Suit

Sandata Technologies, Inc., a leading nationwide provider of information technology...

Friday, March 05, 2010 Source: Sandata Technologies, Inc.

Patent Issued For Humanetics’ BIO 300 Radiation Countermeasure Drug

In an announcement today, Humanetics Corporation reported that its BIO 300 medical...

Friday, March 05, 2010 Source: BUSINESS WIRE
Page
12345»

News Search

Search News By Keywords
advertisement

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






Select All

Loading

Loading